You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 146 No. 9, September 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nephrotic Syndrome Associated With a Clonal T-Cell Leukemia of Large Granular Lymphocytes With Cytotoxic Function

Stephen V. Orman, MD; Geraldine P. Schechter, MD; Jacqueline Whang-Peng, MD; John Guccion, MD; Clara Chan, MD; Richard S. Schulof, MD; Robert J. Shalhoub, MD

Arch Intern Med. 1986;146(9):1827-1829.


Abstract

• A 51-year-old man presented with a T-cell leukemia of large granular lymphocytes and rapidly developed a nephrotic syndrome due to presumptive minimal-change glomerulopathy. The E-rosette+, la+ cells demonstrated cytotoxic activity similar to that of natural killer lymphocytes but lacked other T-subset markers, except that one third of them bore Fc(IgG) receptors. Cytogenetic analysis revealed loss of chromosome 10 and the translocation (1;10)(p11;q11) in all metaphases. Regression of the leukemia after chemotherapy was accompanied by a dramatic resolution of the nephrotic syndrome, suggesting that the activated granular lymphocytes induced the renal lesion. The close association of a clonal T-lymphoproliferative disorder with minimal-change nephrotic syndrome lends further support to current views implicating activated T cells or their products in the pathogenesis of this glomerulopathy.

(Arch Intern Med 1986;146:1827-1829)



Author Affiliations

From the Medical and Laboratory Services, Veterans Administration Medical Center (Drs Orman, Schechter, Guccion, Chan, and Shalhoub); the Departments of Medicine and Pathology of George Washington University (Drs Orman, Schechter, Guccion, Chan, and Schulof); and the Department of Medicine of Georgetown University (Dr Shalhoub), Washington, DC; and the National Cancer Institute, National Institutes of Health, Bethesda, Md (Dr Whang-Peng).


Footnotes

Accepted for publication March 7, 1986.

Reprint requests to Hematology Section, Veterans Administration Medical Center, 50 Irving St NW, Washington, DC 20422 (Dr Schechter).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.